{"organizations": [], "uuid": "8b3888dc19cd9ea56ef62f2a00cbb95a02303779", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-erytech-to-present-results-from-ph/brief-erytech-to-present-results-from-phase-i-trial-of-eryaspase-in-all-and-new-pre-clinical-data-at-aacr-2018-idUSASC09VMU", "country": "US", "domain_rank": 408, "title": "BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T13:16:00.000+03:00", "replies_count": 0, "uuid": "8b3888dc19cd9ea56ef62f2a00cbb95a02303779"}, "author": "", "url": "https://www.reuters.com/article/brief-erytech-to-present-results-from-ph/brief-erytech-to-present-results-from-phase-i-trial-of-eryaspase-in-all-and-new-pre-clinical-data-at-aacr-2018-idUSASC09VMU", "ord_in_thread": 0, "title": "BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "erytech pharma sa", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 12, 2018 / 10:18 AM / Updated 11 minutes ago BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018 Reuters Staff 1 Min Read \nApril 12 (Reuters) - Erytech Pharma SA: \n* ERYTECH TO PRESENT RESULTS FROM PHASE I TRIAL OF ERYASPASE IN ALL AND NEW PRE-CLINICAL DATA AT AACR 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-12T13:16:00.000+03:00", "crawled": "2018-04-12T13:38:35.082+03:00", "highlightTitle": ""}